2FD6 image
Deposition Date 2005-12-13
Release Date 2006-02-21
Last Version Date 2024-11-20
Entry Detail
PDB ID:
2FD6
Title:
Structure of Human Urokinase Plasminogen Activator in Complex with Urokinase Receptor and an anti-upar antibody at 1.9 A
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Urokinase-type plasminogen activator
Gene (Uniprot):PLAU
Chain IDs:A
Chain Length:122
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:H chain of Fab of ATN-615 anti-uPAR antibody
Chain IDs:C (auth: H)
Chain Length:213
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:L chain of Fab of ATN-615 anti-uPAR antibody
Gene (Uniprot):Igkv8-30
Chain IDs:B (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Urokinase plasminogen activator surface receptor
Gene (Uniprot):PLAUR
Chain IDs:D (auth: U)
Chain Length:276
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN D ASN GLYCOSYLATION SITE
Primary Citation
Structure of human urokinase plasminogen activator in complex with its receptor
Science 311 656 659 (2006)
PMID: 16456079 DOI: 10.1126/science.1121143

Abstact

The urokinase plasminogen activator binds to its cellular receptor with high affinity and initiates signaling cascades that are implicated in pathological processes including tumor growth, metastasis, and inflammation. We report the crystal structure at 1.9 angstroms of the urokinase receptor complexed with the urokinase amino-terminal fragment and an antibody against the receptor. The three domains of urokinase receptor form a concave shape with a central cone-shaped cavity where the urokinase fragment inserts. The structure provides insight into the flexibility of the urokinase receptor that enables its interaction with a wide variety of ligands and a basis for the design of urokinase-urokinase receptor antagonists.

Legend

Protein

Chemical

Disease

Primary Citation of related structures